NANETS produces a monthly eNewsletter, Net News. Net News contains information on recent NET disease research, guidelines and resources. It also highlights NET continuing medical education (CME) programming, medical society developments, member accomplishments and news from other NET organizations. Have news to share? Contact us! Net News is a benefit of membership in NANETS. Not a member? Subscribe now!


 

In 2021, NANETS is pleased to offer two research grants to encourage young researchers and scientific clinicians to become NET specialists. The NANETS research grant submission portal opened May 1 and will accept submissions through July 2, 11:59 PM PDT. Interested applications can access the research grant submission portal here.
NANETS Clinical Investigator Scholarship (NCIS): The NCIS is a $100,000 scholarship awarded over a two-year period that emphasizes both the professional development of the scientific clinician (whose time is primarily dedicated to patient care) and the potential of the project to directly impact NET patients. Learn more here.

NANETS Basic/Translational Science Investigator (BTSI): The BTSI is a $100,000 grant awarded over the period of two years to scientists at the end of their fellowship or in the beginning of their faculty appointments who are predominantly focused on lab-based, basic/translational research. Learn more here.

Special thanks to Ipsen Biopharmaceuticals and The Neuroendocrine Tumor Research Foundation (NETRF) for their sponsorship and support of NANETS' 2021 research grant program. Visit our website for more information and instructions on how to apply.

 

Saturday, June 26, 12 PM - 5 PM ET / 9 AM - 2 PM PT

Join the NET medical community for a dynamic half-day of NET education. An interactive patient program immediately follows the medical conference. Learn more, register now, and be sure to share this information with your colleagues!

Despite not gathering in person, this virtual half-day of continuing education provides attendees an intimate learning environment and opportunities for engagement with speakers and panelists. The education is highly interactive and a provides a visually rich learning environment from your computer, tablet or mobile device.

NANETS' NET Symposium Committee member Sukhmani K. Padda, MD has been selected to direct thoracic medical oncology at Cedars-Sinai.

SukhmaniPaddaHeadshot.jpg 

“I am excited to expand clinical trials in thoracic medical oncology within the greater Los Angeles area and the growing Cedars-Sinai Cancer network so that patients with thoracic malignancies, including lung cancer, lung neuroendocrine tumors, thymic malignancies and malignant mesothelioma, have access to these novel therapies," shares Dr. Padda.
"I also very much look forward to working with the scientists at Cedars-Sinai Cancer on translational work, including novel targets and biomarkers- all with the ultimate goal to improve the care of patients with thoracic malignancies." Click here to read more about Dr. Padda's transition.